Wellington Management Group LLP lifted its holdings in Humana Inc. (NYSE:HUM – Free Report) by 7.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 765,355 shares of the insurance provider’s stock after acquiring an additional 52,004 shares during the period. Wellington Management Group LLP owned approximately 0.64% of Humana worth $304,014,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the business. Beacon Pointe Advisors LLC acquired a new stake in Humana in the 2nd quarter worth about $864,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new position in shares of Humana during the 2nd quarter worth approximately $365,000. Rakuten Investment Management Inc. bought a new position in shares of Humana during the second quarter worth approximately $7,637,000. Glenview Trust Co acquired a new stake in shares of Humana in the second quarter valued at approximately $17,354,000. Finally, Palo Alto Investors LP acquired a new stake in shares of Humana in the second quarter valued at approximately $1,582,922. 92.38% of the stock is owned by institutional investors.
Humana Stock Up 0.4%
NYSE HUM opened at $386.92 on Monday. The business has a fifty day moving average price of $385.60 and a two-hundred day moving average price of $289.17. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The stock has a market capitalization of $46.46 billion, a PE ratio of 36.61, a PEG ratio of 2.20 and a beta of 0.72.
Wall Street Analysts Forecast Growth
HUM has been the subject of several recent research reports. Guggenheim boosted their price target on Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Piper Sandler raised Humana from a “hold” rating to an “overweight” rating and set a $463.00 price objective for the company in a report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft assumed coverage on Humana in a research report on Thursday, July 30th. They set a “hold” rating for the company. Barclays increased their target price on Humana from $344.00 to $407.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Finally, Lake Street Capital started coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $403.91.
View Our Latest Report on Humana
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
